View : 687 Download: 0

Effect of Metabolic Syndrome on the Outcome of Corticosteroid Injection for Trigger Finger: Matched Case-Control Study

Title
Effect of Metabolic Syndrome on the Outcome of Corticosteroid Injection for Trigger Finger: Matched Case-Control Study
Authors
Roh, Young HakLee, Beom KooKim, Jong KeunNoh, Jung HoGong, Hyun SikBaek, Goo Hyun
Ewha Authors
노영학
SCOPUS Author ID
노영학scopus
Issue Date
2016
Journal Title
JOURNAL OF HAND SURGERY-AMERICAN VOLUME
ISSN
0363-5023JCR Link

1531-6564JCR Link
Citation
JOURNAL OF HAND SURGERY-AMERICAN VOLUME vol. 41, no. 10, pp. E331 - E335
Keywords
Trigger fingermetabolic syndromecorticosteroid injection
Publisher
W B SAUNDERS CO-ELSEVIER INC
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Purpose To compare the efficacy of corticosteroid injections in treating trigger finger in patients with and without metabolic syndrome (MS). Methods Fifty-one patients with trigger finger and MS were matched for age and sex with 52 control patients without MS. All patients were treated with a single corticosteroid injection. The response to treatment, including objective triggering, tenderness at the A1 pulley, and Quick Disabilities of the Arm, Shoulder, and Hand score (QuickDASH) were assessed at 6, 12, and 24 weeks' follow-up. Before the 24-week evaluation, 7 in the MS group and 10 in the control group were lost to follow-up. Results Prior to treatment, patients with MS had Quinnell grades and initial mean QuickDASH scores similar to those in the control group. The proportion of treatment failure for the MS group (49%) was significantly higher than that of control group (19%) after 6 months' followup. Unresolved triggering was more prevalent in patients in the MS group at the 12- and 24-week follow-ups. Local tenderness was more persistent in the MS group than in the control group throughout the 24 weeks of follow-up. After 24 weeks of follow-up, 14 patients (27%) in the MS group and 6 (12%) in the control group underwent surgical release. QuickDASH scores of the MS group were worse than those of the control group at the 12- and 24-week follow-ups. Conclusions Trigger finger patients with MS are at risk of poorer functional outcomes and treatment failure after a single corticosteroid injection than age- and sex-matched controls. Copyright (C) 2016 by the American Society for Surgery of the Hand. All rights reserved.
DOI
10.1016/j.jhsa.2016.07.091
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE